CSL Vows To Fix Flaws In Producing Vaccines
This article was originally published in PharmAsia News
Executive Summary
Australia's CSL, focus of attention for U.S. FDA allegations, supported by the Therapeutic Goods Administration, of vaccine-production flaws, said it was fixing the problems addressed